AI agent disclosures in SEC filings, deployment confirmed
As of 2026-02-27, HEALTHSTREAM INC (HSTM) disclosed AI-agent language in 1 SEC filing since 2026-02-27, including 1 excerpt describing its own deployment of AI agents (source: Agentic 10-K, from SEC EDGAR).
None identified
None named
1 filing since 2025-01-01. All EDGAR filings (opens in a new tab)
Stage and function are keyword-rule labels, not the company’s words.
Sentences copied from the filings, whitespace normalised.
“We are investing in AI, including generative AI and agentic AI technologies, in certain aspects of our products, services, and internal operations.”
“The development and use of AI or the failure to adequately or appropriately develop and use AI, including generative AI and agentic AI, may result in reputational harm, liability, and adverse financial results, and could impact our value proposition.”
Development or failure to use AI including agentic AI may cause reputational harm and adverse results.
“The development and use of AI or the failure to adequately or appropriately develop and use AI, including generative AI and agentic AI, may result in reputational harm, liability, and adverse financial results, and could impact our value proposition.”
HealthStream is investing in AI including generative and agentic AI in products, services, and operations.
“We are investing in AI, including generative AI and agentic AI technologies, in certain aspects of our products, services, and internal operations. AI technology and services are a highly competitive and rapidly evolving market. If we are unable to successfully innovate, compete effectively, or differentiate our AI-enabled offerings relative to competitors, or if competitors or customers deploy AI technologies more rapidly or effectively than we do, our market position could be adversely affected.”
HealthStream references risk factors on development and use of AI including agentic AI.
“Additional information regarding the risks associated our use of AI, including regulatory, operational, and reputational risks, is included in Section 1A – Risk Factor “The development and use of AI or the failure to adequately or appropriately develop and use AI, including generative AI and agentic AI, may result in reputational harm, liability, and adverse financial results, and could impact our value proposition.””